Professional Documents
Culture Documents
Psychoneuroimmunology: F T, I E & J M
Psychoneuroimmunology: F T, I E & J M
DERMATOLOGIC THERAPY
ISSN 1396-0296
Psychoneuroimmunology
ABSTRACT: Psychoneuroimmunology (PNI) is a discipline that has evolved in the last 40 years to
study the relationship between immunity, the endocrine system, and the central and peripheral
nervous systems. In this manner, neurotransmitters, hormones, and neuropeptides have been found
to regulate immune cells, and these in turn are capable of communicating with nervous tissue
through the secretion of a wide variety of cytokines. Of critical importance is the effect of products of
the CNS and nerves on the maintenance of the delicate balance between cell-mediated (Th1) and
humoral (Th2) immune responses. A good example of how this concept operates in vivo becomes
evident when analyzing the effects of stressors. Chronic stress affects significantly the function of the
immune system as well as modifies the evolution of a variety of skin diseases, as psychosocial interventions have proved to be effective in their therapy.
KEYWORDS: dermatology, neuropeptides, psychoneuroimmunology, stress
Introduction:
Psychoneuroimmunology
The study of mindbody interactions can be traced
back to the time of Hippocrates (c. 460 BC360 BC),
although this early work appeared to have been
focused more on body-to-brain regulation rather
than on brain regulation of physical health (1).
The discipline of psychoneuroimmunology (PNI)
can be argued to have formally begun its emergence in the mid 1970s, with the seminal work of
Ader and Cohen (2) and the finding that changes
in immune function could be behaviorally conditioned, in a manner analogous to the classical
conditioning studies of Pavlov and his canine
subjects. From a practical perspective, that the
central nervous system (CNS) might regulate
immune function, and further, that the immune
system might communicate with the CNS, seems
quite logical and to have clear adaptive value.
For example, it would makes sense for the brain
Address correspondence and reprint requests to: Francisco
Tausk, MD, Department of Dermatology, University of
Rochester, 601 Elmwood Ave., BOX 697, Rochester, NY 14642, or
email: Francisco_Tausk@URMC.Rochester.edu.
Adapted from Tausk et al., with permission from Gaspari A,
Tyring S, Clinical Immunodermatology London: Springer; 2007
(In press)
22
to warn the innate immune system of an impending wound to be inflicted by a predator, and for
lymphocytes to become mobilized to the skin in
anticipation. As the brain functions as the control
center for the entire body, it is entrusted with
maintaining constant communication with all other
bodily systems, resulting in integrated function of
all systems. However, as our understanding of
immunology largely unfolded in the Petri dish,
immunologists had become quite convinced that
the cells of the immune system function often
autonomously, and are regulated only by each
other. Although it is indeed the case that immune
responses can be elicited in vitro, and such studies have been critical for our understanding of
mechanisms of immune function, immunologists
were resistant to the consideration that immune
responses in vivo take place in an environment
that contains nerve fibers, neurotransmitters, and
hormones. Thus, the early days of PNI were
fraught with tension, as the hard evidence for
brain-behavior-immune system interactions was,
initially, scant.
At the present time, there is no longer much
question that the nervous and immune systems
are tightly connected. In addition to growing
support for behavioral conditioning of a variety of
types of immune responses, four additional important
Psychoneuroimmunology
23
Tausk et al.
24
Psychoneuroimmunology
25
Tausk et al.
26
Psychoneuroimmunology
Conclusions
Psychoneuroimmunology is an evolving area of
science that will help us understand the relationship between the mind and the body. The past 30
years of research in the field of PNI have validated
the close relationship between the CNS and the
immune system. There is a growing body of evidence to support the effect of the psyche stress,
in particular on immune responses and a multitude of skin conditions. The effects of stress on
shifting the immune response are not completely
understood; however, research has shown that
stress modifies the delicate balance between health
and disease. Just as interesting are the numerous
studies demonstrating that a nonpharmacologic
approach can ameliorate certain dermatologic diseases. Seeking alternative interventions can only
enhance our ability to treat patients.
References
1. Medicine NLo. Emotions and Disease: an exhibition at
the National Library of Medicine. Friends of the National
Library of Medicine 1997.
2. Ader R, Cohen N. Behaviorally conditioned immunosuppression. Psychosom Med 1975: 37: 333340.
3. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain
27
Tausk et al.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
28
communication: a review and analysis of alternative mechanisms. Life Sci 1995: 57: 10111026.
Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye
Memorial Lecture. Ann N Y Acad Sci 1998: 851: 311335.
Charmandari E, Tsigos C, Chrousos G. Endocrinology
of the stress response. Annu Rev Physiol 2005: 67: 259
284.
Dunn A. Psychoneuroimmunology, stress and infection.
In: Friedman K, ed. Psychoneuroimmunology, stress, infection. Boca Raton, FL: CRC, 1995: 2545.
Sternberg EM. Overview of the conference and the field.
Ann N Y Acad Sci 1998: 840: 1 8.
McEwen BS. Protection and damage from acute and
chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders.
Ann N Y Acad Sci 2004: 1032: 17.
Korte SM, Koolhaas JM, Wingfield JC, McEwen BS. The
Darwinian concept of stress: benefits of allostasis and
costs of allostatic load and the trade-offs in health and
disease. Neurosci Biobehav Rev 2005: 29: 338.
Moynihan JA, Stevens SY. Mechanisms of stress-induced
modulation of immunity in animals. In: Ader R, Felten
DL, Cohen N, eds. Psychoneuroimmunology. New York:
Academic Press, 2001: 227249.
Levite M. Neuropeptides, by direct interaction with T
cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci
USA 1998: 95: 1254412549.
Khansari DN, Murgo AJ, Faith RE. Effects of stress on the
immune system. Immunol Today 1990: 11: 170175.
Baker C, Richards LJ, Dayan CM, Jessop DS. Corticotropin-releasing hormone immunoreactivity in human T
and B cells and macrophages: colocalization with arginine
vasopressin. J Neuroendocrinol 2003: 15: 10701074.
Gerlo S, Verdood P, Hooghe-Peters EL, Kooijman R. Modulation of prolactin expression in human T lymphocytes
by cytokines. J Neuroimmunol 2005: 162: 190193.
Lysle DT, Lyte M, Fowler H, Rabin BS. Shock-induced
modulation of lymphocyte reactivity: suppression, habituation, and recovery. Life Sci 1987: 41: 18051814.
Urpe M, Buggiani G, Lotti T. Stress and psychoneuroimmunologic factors in dermatology. Dermatol Clin 2005: 23:
609 617.
Saraceno R, Kleyn CE, Terenghi G, Griffiths CE. The role
of neuropeptides in psoriasis. Br J Dermatol 2006: 155:
876 882.
Dhabhar FS, McEwen BS. Acute stress enhances while
chronic stress suppresses cell-mediated immunity in
vivo: a potential role for leukocyte trafficking. Brain Behav
Immun 1997: 11: 286306.
Dhabhar FS. Stress-induced enhancement of cell-mediated
immunity. Ann N Y Acad Sci 1998: 840: 359372.
Dhabhar FS, McEwen BS. Enhancing versus suppressive
effects of stress hormones on skin immune function. Proc
Natl Acad Sci USA 1999: 96: 10591064.
Glaser R, Kiecolt-Glaser JK, Speicher CE, Holliday JE.
Stress, loneliness, and changes in herpesvirus latency. J
Behav Med 1985: 8: 249260.
Glaser R, Kiecolt-Glaser JK, Bonneau RH, Malarkey W,
Kennedy S, Hughes J. Stress-induced modulation of the
immune response to recombinant hepatitis B vaccine.
Psychosom Med 1992: 54: 2229.
Marucha PT, Kiecolt-Glaser JK, Favagehi M. Mucosal
wound healing is impaired by examination stress. Psychosom Med 1998: 60: 362365.
24. Kiecolt-Glaser JK, Loving TJ, Stowell JR, et al. Hostile marital interactions, proinflammatory cytokine production,
and wound healing. Arch Gen Psychiatry 2005: 62: 1377
1384.
25. Emery CF, Kiecolt-Glaser JK, Glaser R, Malarkey WB, Frid DJ.
Exercise accelerates wound healing among healthy older
adults: a preliminary investigation. J Gerontol 2005: 60:
14321436.
26. Sandoz A, Kusnir D, Koenig T, Tausk F Psychocutaneous
medicine. In: Fitzpatricks dermatology in general medicine. New York: Mc Graw-Hill, 2007.
27. Chrousos GP. The hypothalamic-pituitary-adrenal axis
and immune-mediated inflammation. N Engl J Med 1995:
332: 13511362.
28. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve an integrative interface between two supersystems: the brain and the immune system. Pharmacol
Rev 2000: 52: 595638.
29. Besedovsky HO, del Rey AE, Sorkin E. What do the
immune system and the brain know about each other.
Immunol Today 1983: 4: 342346.
30. Besedovsky H, del Rey A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986: 233: 652654.
31. Fearon DT, Locksley RM. The instructive role of innate
immunity in the acquired immune response. Science
1996: 272: 5053.
32. Mosmann TR, Sad S. The expanding universe of T-cell
subsets: Th1, Th2 and more. Immunol Today 1996: 17:
138146.
33. Trinchieri G. Interleukin-12 and the regulation of innate
resistance and adaptive immunity. Nature Rev 2003: 3:
133146.
34. Elenkov IJ, Chrousos GP. Stress Hormones, Th1/Th2
patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 1999: 10:
359368.
35. Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP.
Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians
1996: 108: 374381.
36. Blotta MH, DeKruyff RH, Umetsu DT. Corticosteroids
inhibit IL-12 production in human monocytes and
enhance their capacity to induce IL-4 synthesis in CD4+
lymphocytes. J Immunol 1997: 158: 55895595.
37. Hasko G, Szabo C, Nemeth ZH, Salzman AL, Vizi ES. Stimulation of beta-adrenoceptors inhibits endotoxin-induced
IL-12 production in normal and IL-10 deficient mice. J
Neuroimmunol 1998: 88: 5761.
38. Panina-Bordignon P, Mazzeo D, Lucia PD, et al. Beta2agonists prevent Th1 development by selective inhibition
of interleukin 12. J Clin Invest 1997: 100: 15131519.
39. Ramirez F, Fowell DJ, Puklavec M, Simmonds S,
Mason D. Glucocorticoids promote a TH2 cytokine
response by CD4+ T cells in vitro. J Immunol 1996: 156:
24062412.
40. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ,
Fuchs BA, Street NE. Differential expression of the beta2adrenergic receptor by Th1 and Th2 clones: implications
for cytokine production and B cell help. J Immunol 1997:
158: 42004210.
41. Chiu A, Chon SY, Kimball AB. The response of skin disease to stress: changes in the severity of acne vulgaris as
affected by examination stress. Arch Dermatol 2003: 139:
897900.
Psychoneuroimmunology
42. Papadopoulos L, Bor R, Legg C, Hawk JL. Impact of life
events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clin Exp
Dermatol 1998: 23: 243248.
43. Barisic-Drusko V, Rucevic I. Trigger factors in childhood
psoriasis and vitiligo. Coll Antropol 2004: 28: 277285.
44. Gulec AT, Tanriverdi N, Duru C, Saray Y, Akcali C. The
role of psychological factors in alopecia areata and the
impact of the disease on the quality of life. Int J Dermatol
2004: 43: 352356.
45. Chaudhary S. Psychosocial stressors in oral lichen planus.
Aust Dent J 2004: 49: 192195.
46. Cohen F, Kemeny ME, Kearney KA, Zegans LS, Neuhaus
JM, Conant MA. Persistent stress as a predictor of genital
herpes recurrence. Arch Intern Med 1999: 159: 24302436.
47. Goldberg I, Ingher A, Brenner S. Pemphigus vulgaris triggered by rifampin and emotional stress. Skinmed 2004: 3:
294.
48. Berrino AM, Voltolini S, Fiaschi D, et al. Chronic urticaria:
importance of a medical-psychological approach. Allerg
Immunol 2006: 38: 149152.
49. Naldi L, Peli L, Parazzini F, Carrel CF. Family history of
psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate
psoriasis: results of a case-control study. J Am Acad Dermatol 2001: 44: 433438.
50. Fortune DG, Richards HL, Griffiths CEM, Main CJ. Psychological stress, distress and disability in patients with
psoriasis: consensus and variation in the contribution
of illness perceptions, coping and alexithymia. Br J Dermatol 2002: 41: 157174.
51. Fortune DG, Richards HL, Griffiths CEM, Main CJ. Psychologic factors in psoriasis: consequences, mechanisms,
and interventions. Dermatol Clin 2005: 4: 681694.
52. Raychaudhuri SP, Farber FE, Raychaudhuri SK. Role of
nerve growth factor in RANTES expression by keratinocytes. Acta Derm Venereol 2000: 80: 247250.
53. Nickoloff BJ, Schroder JM, von den Driesch P, et al. Is Psoriasis a T-cell disease? Exp Dermatol 2000: 9: 357375.
54. Farber EM, Nall L. Psoriasis: a stress-related disease. Cutis
1993: 51: 322326.
55. Farber EM, Nickoloff BJ, Recht B, Fraki JE. Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am
Acad Dermatol 1986: 14: 305311.
56. Aloe L, Alleva E, Fiore M. Stress and nerve growth factor:
findings in animal models and humans. Pharmacol Biochem Behav 2002: 73: 159166.
57. Raychaudhuri SP, Jiang WY, Farber EM. Psoriatic keratinocytes express high levels of nerve growth factor. Acta
Derm Venereol 1998: 78: 8486.
58. Raychaudhuri SP, Jiang WY, Smoller BR, Farber EM.
Nerve growth factor and its receptor system in psoriasis.
Br J Dermatol 2000: 143: 198200.
59. Richards HL, Ray DW, Kirby B, et al. Response of the
hypothalamic-pituitary-adrenal axis to psychological
stress in patients with psoriasis. Br J Dermatol 2005: 153:
11141120.
60. Schmid-Ott G, Jacobs R, Jger B, et al. Stress induced
endocrine and immunological changes in psoriasis
patients and healthy controls. Psychother Psychosom
1998: 67: 3742.
61. Ginsburg IH. Coping with psoriasis: a guide for counseling patients. Cutis 1996: 57: 323325.
62. Tausk F, Whitmore SE. A pilot study of hypnosis in the
treatment of patients with psoriasis. Psychother Psychosom 1999: 68: 221225.
29
Tausk et al.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
30
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
Psychoneuroimmunology
114. Herberman RB, Ortaldo JR. Natural killer cells: their
roles in defenses against disease. Science 1981: 214: 24
30.
115. Esterling BA, Kiecolt-Glaser JK, Glaser R. Psychosocial
modulation of cytokine-induced natural killer cell activity
in older adults. Psychosom Med 1996: 58: 264272.
116. Kiecolt-Glaser JK, Garner W, Speicher C, Penn GM,
Holliday J, Glaser R. Psychosocial modifiers of immunocompetence in medical students. Psychosom Med 1984:
46: 714.
117. Glaser R, Rice J, Speicher CE, Stout JC, Kiecolt-Glaser JK.
Stress depresses interferon production by leukocytes
concomitant with a decrease in natural killer cell activity.
Behav Neurosci 1986: 100: 675678.
31